AXIM Biotechnologies Statistics
Total Valuation
AXIM has a market cap or net worth of $3.68 million. The enterprise value is $9.47 million.
Market Cap | 3.68M |
Enterprise Value | 9.47M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
AXIM has 237.65 million shares outstanding. The number of shares has increased by 178.37% in one year.
Shares Outstanding | 237.65M |
Shares Change (YoY) | +178.37% |
Shares Change (QoQ) | +111.48% |
Owned by Insiders (%) | 33.26% |
Owned by Institutions (%) | n/a |
Float | 174.57M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 106.87 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 274.83 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
Current Ratio | 0.01 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -13.71 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -178.48% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $5,745 |
Profits Per Employee | -$1.20M |
Employee Count | 6 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, AXIM has paid $1.07 million in taxes.
Income Tax | 1.07M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.03% in the last 52 weeks. The beta is 1.40, so AXIM's price volatility has been higher than the market average.
Beta (1Y) | 1.40 |
52-Week Price Change | -53.03% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.02 |
Relative Strength Index (RSI) | 57.01 |
Average Volume (30 Days) | 466,203 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AXIM had revenue of $34,468 and -$7.22 million in losses. Loss per share was -$0.03.
Revenue | 34,468 |
Gross Profit | -392,637 |
Operating Income | -3.14M |
Pretax Income | -7.06M |
Net Income | -7.22M |
EBITDA | -2.71M |
EBIT | -3.14M |
Loss Per Share | -$0.03 |
Balance Sheet
The company has $23,220 in cash and $5.81 million in debt, giving a net cash position of -$5.79 million or -$0.02 per share.
Cash & Cash Equivalents | 23,220 |
Total Debt | 5.81M |
Net Cash | -5.79M |
Net Cash Per Share | -$0.02 |
Equity / Book Value | -5.96M |
Book Value Per Share | -0.03 |
Working Capital | -4.25M |
Cash Flow
In the last 12 months, operating cash flow was -$1.37 million and capital expenditures $8,710, giving a free cash flow of -$1.36 million.
Operating Cash Flow | -1.37M |
Capital Expenditures | 8,710 |
Free Cash Flow | -1.36M |
FCF Per Share | -$0.00 |
Margins
Gross margin is -1,139.13%, with operating and profit margins of -9,107.76% and -20,939.79%.
Gross Margin | -1,139.13% |
Operating Margin | -9,107.76% |
Pretax Margin | -20,472.62% |
Profit Margin | -20,939.79% |
EBITDA Margin | -7,868.62% |
EBIT Margin | -9,107.76% |
FCF Margin | -3,936.55% |
Dividends & Yields
AXIM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -178.37% |
Shareholder Yield | -178.37% |
Earnings Yield | -195.94% |
FCF Yield | -36.84% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AXIM has an Altman Z-Score of -27.93 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -27.93 |
Piotroski F-Score | 3 |